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Research
All-cause, cardiopulmonary, cardiovascular, 
and lung-cancer mortality have been associ-
ated with chronic air pollution exposure in 
prospective studies that controlled for indi-
vidual covariates (Abbey et al. 1999; Beelen 
et al. 2008b; Beeson et al. 1998; Cao et al. 
2011; Dockery et al. 1993; Eftim et al. 2008; 
Filleul et al. 2005; Gehring et al. 2006; 
Katanoda et al. 2011; Laden et al. 2006; 
Miller et al. 2007; Nafstad et al. 2004; Ostro 
et al. 2010; Pope et al. 2002; Puett et al. 
2009; Yorifuji et al. 2011). The studies that 
specifically considered lung-cancer mortality 
associations with fine particles (aerodynamic 
diameter < 2.5 µm; PM2.5), all found positive 
associations (Beelen et al. 2008b; Dockery 
et al. 1993; Laden et al. 2006; McDonnell 
et al. 2000), although this association was 
only statistically significant (p < 0.05) in the 
American Cancer Society study (ACS) (Pope 
et al. 2002; Turner et al. 2011).
Although compelling evidence sup-
ports the harmful effects of PM2.5 on lon-
gevity, concerns have been raised regarding 
the sensitivity of the results to model speci-
fications. In particu  lar, Moolgavkar (2005, 
2007) suggested that covariates may not be 
proportional and hence were not controlled 
for properly in proportional hazards models;   
that the concentration–response relation 
may not be linear; and that there are few 
observations at levels as low as or below the 
current World Health Organization and U.S. 
Environmental Protection Agency (EPA) air 
quality standards. In addition, the relative tox-
icity of particle elements is still controversial, 
and most of the recent reduction in PM2.5 
concentrations in the United States has come 
from sulfate control. Hence it is of interest 
whether the concentration–response curve has 
changed over time as particle composition has 
changed. Health impact assessments in the 
United States assume that health benefits of 
reducing particles are only fully realized after 
20 years (U.S. EPA 2010), so examination 
of the lag between exposure and mortality is 
also relevant for consideration of changes in 
the standard.
Our goal was to test the robustness of 
the association between chronic exposure to 
PM2.5 and mortality observed in the origi-
nal study (Dockery et al. 1993), and the first 
extended follow-up of the Harvard Six Cities 
study (Laden et al. 2006) by replicating the 
analyses using 11 additional years of follow-up 
with exposures well below the U.S. annual 
standard (15 µg/m3) (U.S. EPA 1997). We 
examined different lags of exposure, tested the 
shape of the PM2.5 concentration–  mortality 
relationship, tested for changes in this slope 
over time, and relaxed the proportion assump-
tion by allowing the effects of covariates to 
vary each year. We reexamined the association 
of PM2.5 with specific causes of death such as 
lung cancer and examined the effects of PM2.5 
depending on participants’ chronic conditions 
and smoking status.
Methods
Study population. The Harvard Six Cities 
study population has been previously described 
(Dockery et al. 1993). Briefly, adults were ran-
domly sampled from six cities in the eastern 
and midwestern United States between 1974 
and 1977: in 1974, Watertown, Massachusetts; 
in 1975, Kingston and Harriman, Tennessee, 
and specific census tracts of St. Louis, 
Missouri; in 1976, Steubenville, Ohio, and 
Portage, Wyocena, and Pardeeville, Wisconsin; 
and in 1977, Topeka, Kansas. Information 
on age, sex, weight, height, educational level, 
smoking history, hypertension, and diabetes 
was collected by questionnaire at enrollment. 
All participants underwent spirometry tests at 
enrollment (Dockery et al. 1985) and chronic 
obstructive pulmonary disease (COPD) was 
defined as having
  (FEV1 ÷ FVC) < 70%, 
where FEV1 is forced expiratory volume in 
1 sec, and FVC is forced vital capacity. This 
analysis, as in the previous analyses, was 
restricted to 8,096 white participants with 
acceptable pulmonary function measurements. 
The study was approved by the Harvard 
School of Public Health Human Subjects 
Committee and all participants signed an 
informed consent before participation.
Mortality follow-up. Vital status and 
cause of death were determined by searching 
the National Death Index (NDI) for calendar 
years 1979–2009. Deaths before the NDI 
started in 1979 were identified by next of kin 
and Social Security records, and the cause of 
death was determined by a certified nosologist 
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Ba c k g r o u n d: Epidemiologic studies have reported associations between fine particles (  aerodynamic 
diameter ≤ 2.5 µm; PM2.5) and mortality. However, concerns have been raised regarding the sensi-
tivity of the results to model specifications, lower exposures, and averaging time.
oB j e c t i v e: We addressed these issues using 11 additional years of follow-up of the Harvard Six 
Cities study, incorporating recent lower exposures.
Me t h o d s : We replicated the previously applied Cox regression, and examined different time lags, 
the shape of the concentration–response relationship using penalized splines, and changes in the 
slope of the relation over time. We then conducted Poisson survival analysis with time-varying 
effects for smoking, sex, and education.
re s u l t s: Since 2001, average PM2.5 levels, for all six cities, were < 18 µg/m3. Each increase in 
PM2.5 (10 µg/m3) was associated with an adjusted increased risk of all-cause mortality (PM2.5 
average on previous year) of 14% [95% confidence interval (CI): 7, 22], and with 26% (95% CI: 
14, 40) and 37% (95% CI: 7, 75) increases in cardiovascular and lung-cancer mortality (PM2.5 
average of three previous years), respectively. The concentration–response relationship was linear 
down to PM2.5 concentrations of 8 µg/m3. Mortality rate ratios for PM2.5 fluctuated over time, 
but without clear trends despite a substantial drop in the sulfate fraction. Poisson models produced 
similar results.
co n c l u s i o n s: These results suggest that further public policy efforts that reduce fine particulate 
matter air pollution are likely to have continuing public health benefits.
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who reviewed death certificates (Dockery 
et al. 1993).
Survival time. Survival times were cal-
culated from enrollment until death or the 
end of follow-up (31 December 2009). For 
the 6 participants who were lost to follow-up 
before 1979, the censored survival times were 
calculated from enrollment to date of the last 
follow-up contact plus 6 months or the first 
day of the NDI (1 January 1979), whichever 
came first. For each cause of death category, 
participants who died from another cause 
were censored at time of death.
Air pollution estimates. Annual PM2.5 con-
centration was assigned for each participant 
until death or censoring. PM2.5 concentration 
was measured in the participant’s city by a cen-
trally located monitor from 1979 to 1986–
1988, depending on the city (Dockery et al. 
1993). Therefore, the study has no spatial con-
trast on the within-city scale. PM2.5 concentra-
tions for the years before monitoring started 
were assumed to be equal to the earliest moni-
tored year. From the end of monitoring until 
1998, PM2.5 concentration was estimated from 
PM10 (aerodynamic diameter < 10 µm) data 
from U.S. EPA monitors and visibility (extinc-
tion) data from the National Weather Service 
(Laden et al. 2006). From 1999 through 2009, 
direct measurements of PM2.5 were available 
from U.S. EPA monitors. For sensitivity analy-
ses, we also predicted PM2.5 for 1999–2009 
(correlation between predicted and measured 
was 0.97) using the formula applied to derive 
exposure estimates during the earlier period 
when PM2.5 was not measured.
Statistical analysis. We first replicated 
the original analysis separately for all-cause 
mortality, cardiovascular mortality as coded by 
the International Classification of Diseases, 9th 
Revision [ICD-9; World Health Organization 
(WHO) 1977] or the 10th Revision (ICD-10; 
WHO 1992), 400.0–440.9, I10.0–I70.9, 
respectively, lung-cancer mortality (ICD-9 
162, ICD-10 C33.0–C34.9), and COPD 
mortality (ICD-9 490.0–496.0, ICD-10 
J40.0–J47.0) for the 36-year follow-  up from 
1974 to 2009 using a Cox proportional haz-
ards model with follow-up time as the time 
scale (Dockery et al. 1993; Laden et al. 2006). 
PM2.5 was included in each model as an 
annual time-dependent variable. The model 
was stratified by sex, age (1-year intervals) 
and time in the study (1-year intervals), so 
that each age/sex group had its own base-
line hazard for each year of follow-up. The 
analysis was adjusted for potential confound-
ers collected at baseline: smoking status 
(never, former, current), cumulative smok-
ing (pack-years included separately for cur-
rent and former smokers), educational level 
(< high-school, ≥ high school), and a linear 
and quadratic term for body mass index 
(BMI; kilograms per meter squared), using 
the Cox proportional hazards model formu-
lated as   follows:
hi s(t) = h0 s(t) exp[β1Xi + β2Zi(t)],   [1]
where hi is the instantaneous hazard probabil-
ity of death for subject i in stratum s (defined 
by sex, age, and time in the study), h0s(t) is 
the baseline hazard function, Xi is the vector of 
time-independent variables, and Zi(t) is the vec-
tor of time-dependent variables. We evaluated 
models with 1-year (i.e., exposure during the 
year before death or censure) to 5-year lagged 
moving averages and chose the best fit model 
using Akaike’s information criterion (AIC) 
(Akaike 1973). The best fit moving average 
was determined from participants who survived 
at least 5 years from enrollment, so that AIC 
criteria were evaluated among populations with 
comparable sizes. We then estimated mortality 
rate ratios (RR) associated with PM2.5 exposure 
during the best fit moving average on the whole 
sample size. Once the best exposure window 
was determined, we fit a penalized spline model 
using a cubic regression spline with 12 knots 
to estimate the shape of the concentration– 
response relation, and chose the optimal degree 
of freedom by minimizing AIC and evaluated 
nonlinearity with a Wald test. We investigated 
whether PM2.5 advanced date of death for par-
ticipants with chronic conditions at enrollment. 
We also investigated the potential for effect 
modification of PM2.5 on mortality by smok-
ing status at enrollment using inter  action terms 
between such variables and PM2.5. Finally, we 
tested the hypothesis that the effect of PM2.5 
changed over time by dividing the follow-up 
into four equally spaced time periods and 
  testing interactions between period and PM2.5.
Sensitivity analyses. We performed sensitiv-
ity analyses using a second-degree poly  nomial 
distributed lag model to allow the effects of 
PM2.5 exposure to be distributed from 1 to 
5 years before death or censor (Lepeule et al. 
2006; Schwartz 2000); using predicted PM2.5 
concentrations after 1999 instead of the mea-
sured PM2.5; considering only deaths from 
natural causes, with external causes of deaths 
(ICD-9 E800–E999, ICD-10 S00–T88 and 
V00–Y99) being censored at time of death; 
and considering only deaths that occurred in 
the state where the participants lived at enroll-
ment. We next investigated the robustness of 
the results to alternative modeling assump-
tions by using a Poisson model with dummy 
variables for each year of follow-up, which is 
equivalent to a piecewise exponential propor-
tionate hazard model with the baseline hazard 
changing each year (Laird and Oliver 1981):
log µit = log Eit + γtTt + β1Xi + β2Zi(t),  [2]
where µit is the expected value of the death 
indicator for subject i at time t, Eit is the 
exposure duration of subject i at time t 
(log Eit being the offset), Tt is the vector of 
dummy variables for time by 1 year (piece-
wise baseline hazard), Xi is the vector of the 
time-independent covariates, and Zi(t) is the 
vector of time-  dependent variables. Using this 
Poisson survival analysis, we first compared 
the results to the Cox model and then relaxed 
the proportionate hazard assumption for 
sex, education, and cumulative smoking by 
including inter  action terms of these variables 
with each year of follow-up. As an alternative 
to the previous analyses (Dockery et al. 1993; 
Laden et al. 2006), we used age in 5-year 
groups as the time scale, and adjusted the 
model for time trends (linear term). For specific 
causes of death, convergence issues led us to 
group age by 10 years. We then fit penalized 
spline models. Because RRs may vary over time 
and period-specific RRs may be biased, we used 
the Poisson model to calculate adjusted survival 
curves (Hernan 2010). We included product 
terms between PM2.5 and time in model 2 
[Equation 2], thereby allowing the effect of 
PM2.5 to flexibly vary from year to year. We 
then predicted the survival probability for each 
year of follow-up for each participant under 
three scenarios using concentrations of PM2.5 
throughout the entire follow-up period equal 
to 10, 15, or 20 µg/m3.
p-Values < 0.05 were considered statistically 
significant. All analyses were repeated separately 
for all- and specific-causes of deaths. Analyses 
were conducted with SAS software, version 9.2 
(SAS Institute Inc., Cary, NC) and R statisti-
cal software, version 2.12.2 (R Foundation for 
Statistical Computing, Vienna, Austria).
Results
Study population. The 8,096 participants were 
25–74 years of age at enrollment (mean ± SD, 
49.6 ± 13.4) and 54.7% were female. More 
than half of the participants had a high school 
degree or higher, 35.8% were current smok-
ers, and 23.9% were former smokers and the 
average BMI was 25.8 ± 4.5. As for chronic 
conditions, 17.8% reported hypertension, 
11.6% COPD, and 6.9% diabetes.
Mortality rates and PM2.5 levels. At the 
end of 2009, there were 212,067 person-years 
of follow-up and 55.5% of the participants had 
died, among whom 40.8% died from cardio-
vascular diseases, 7.8% from lung cancer, and 
5.5% from COPD (Table 1). Overall, PM2.5 
concentration decreased during the study 
period (Figure 1). After 1998, annual aver-
age levels declined by 1.8 µg/m3 in St. Louis 
and by 10.5 µg/m3 in Steubenville, whereas 
levels increased by 1.5 µg/m3 in the Portage–
Wyocena–Pardeeville area. Since 2000, all 
the cities experienced average PM2.5 levels 
< 15 µg/m3 except Kingston–Harriman and 
Steubenville, which had average concentrations 
of ≤ 18 µg/m3.PM2.5 and mortality: the Harvard Six Cities study
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Association between PM2.5 and mortality. 
Using the Cox proportional hazards model, 
statistically significant associations between 
PM2.5 exposure and all-cause, cardio  vascular, 
and lung-cancer mortality were observed 
(Table 2). The AIC indicated lag 1 (i.e., expo-
sure during the previous year) to be the best 
fit exposure window for all-cause mortality 
[see Supplemental Material, Table 1 (http://
dx.doi.org/10.1289/ehp.1104660)]. For 
cause-specific mortality, the best fit moving 
average differed between the Cox and the 
Poisson regressions. Because the differences 
in AIC were very small between the 1- and 
5-year moving averages for both the Cox and 
Poisson regressions, we chose the longer of 
the two moving averages to produce more 
stable results, specifically, a 1- to 3-year mov-
ing average for cardiovascular and lung-cancer 
mortality, and a 1- to 5-year moving average 
for COPD mortality. Each 10-µg/m3 increase 
in PM2.5 was associated with a 14% increased 
risk of all-cause death [95% confidence inter-
val (CI): 7%, 22%], a 26% increase in cardio-
vascular death (95% CI: 14%, 40%), and a 
37% increase in lung-cancer death (95% CI: 
7%, 75%). For both all-cause mortality and 
specific causes of death, the model fit was bet-
ter without the spline (p-values between 0.24 
and 0.43), indicating a linear relationship 
with PM2.5. Results restricted to participants 
with chronic conditions at enrollment (i.e., 
hypertension, COPD, or diabetes) were con-
sistent with those estimated for all participants 
(Table 2). Although, the interaction between 
smoking status and PM2.5 was not statistically 
significant, there was a trend for a stronger 
estimated effect of PM2.5 on mortality in cur-
rent and former smokers. However, positive 
associations between PM2.5 and all-cause and 
cardiovascular mortality were still evident in 
never smokers. RR for PM2.5 fluctuated over 
time for all-cause mortality and specific causes 
of death, without clear trends (Table 2).
Sensitivity analysis. For both all causes and 
specific causes of death, the cumulative effects 
estimated from the polynomial distributed 
lag model were similar to the effect estimates 
obtained with the selected moving averages 
(Table 2). However, the five lags were too 
correlated (between 0.90 and 0.96) to dis-
entangle the relative importance of each one. 
Using predicted PM2.5 instead of measured 
PM2.5 for exposures after 1999, excluding the 
138 deaths from external causes and excluding 
the 702 participants who died in a state other 
than the state where they lived at enrollment, 
did not change the results (data not shown) 
except for the lung-cancer mortality associa-
tion with PM2.5, which was slightly attenuated 
(increased risk of 28%; 95% CI: –2%, 67% 
compared with 37%; 95% CI: 7%, 75%) 
when the 702 participants were excluded.
With the Poisson framework, using basic 
assumptions, relaxed proportionate hazard 
assumption for covariates, or age as the time 
scale, the effect estimates and p-values fluctu-
ated slightly but without any notable change 
in the results compared with estimates from 
the Cox models for all-cause mortality and for 
specific-causes of death (data not shown). The 
penalized spline models also indicated linear 
concentration–response relationships without 
a threshold for PM2.5 and mortality from all-
causes and specific-causes [see Supplemental 
Material, Figure 1 (http://dx.doi.org/10.1289/
ehp.1104660)]. With the Poisson survival 
analysis, we predicted survival assuming every 
participant was exposed to a constant con-
centration of PM2.5 (10, 15, or 20 µg/m3) 
during the entire follow-up period. Adjusted 
Table 1. Number of participants, mortality, and average PM2.5 levels in the Harvard Six Cities study, 1974–2009.
Characteristic
Six cities 
(combined) Steubenville Kingston–Harriman St. Louis Watertown Topeka
Portage–Wyocena–
Pardeeville
Participants (n) 8,096 1,346 1,258 1,292 1,332 1,238 1,630
Person-years (n) 212,067 33,276 33,067 32,225 36,818 32,877 43,804
Cause of death
All causes [n (%)] 4,495 (55.5) 822 (61.1) 733 (58.3) 827 (64.0) 700 (52.6) 617 (49.8) 796 (48.8)
Cardiovascular (%) 40.8 45.3 41.1 42.2 39.3 37.4 38.6
Lung cancer (%) 7.8 9.0 8.0 8.7 6.6 7.3 6.8
COPD (%) 5.5 4.9 7.0 5.1 4.9 7.3 4.6
1974–2009 average of individual 
PM2.5 concentrations
15.9 23.6 19.1 16.7 14.0 12.2 11.4
Figure 1. Annual mean PM2.5 levels during 1974–2009 in the Harvard Six Cities study.
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for individual covariates, the lowest PM2.5 
concentration was associated with the highest 
survival (Figure 2). The three adjusted survival 
curves showed that the proportionate hazard 
was a reasonable assumption for PM2.5 and 
that PM2.5 effects were quite stable over time.
Discussion
Including more recent observations with 
PM2.5 exposures down to 8 µg/m3, we con-
tinued to find a statistically significant asso-
ciation between chronic exposure to PM2.5 
and all-cause and cardiovascular mortality. 
Furthermore, in the present extended follow-
  up, PM2.5 exposure was also statistically 
significantly associated with lung-cancer mor-
tality. Our study indicated no sensitivity of 
the results for all-cause mortality and specific 
causes of death when we allowed the effects 
of smoking, education, and sex to vary over 
time, or when we used age as the time scale 
instead of follow-up time. Using very flexible 
modeling assumptions, our results did not 
show any rationale for change of PM2.5 effect 
size over the whole study period, as indicated 
by the adjusted survival curves and the lack 
of a clear interaction of PM2.5 with the four 
study periods. The concentration–response 
relationship was linear without any threshold, 
even at exposure levels below the U.S. annual 
15-µg/m3 standard (U.S. EPA 1997). Taken 
together with the results of a previous reanaly-
sis of the Harvard Six Cities study (Krewski 
et al. 2005b), there is evidence for a robust 
association between chronic PM2.5 exposure 
and early mortality.
Consistency of the results. Our results indi-
cated a statistically significant 14% increase 
in all-cause mortality for a 10-µg/m3 annual 
increase in PM2.5, which is similar to the results 
of the previous follow-ups (Dockery et al. 
1993; Laden et al. 2006). The Netherlands 
Cohort Study on Diet (NLCS–Air) in Europe 
(Beelen et al. 2008b), the Adventist Study 
(McDonnell et al. 2000), and the male Health 
Professionals Follow-up Study in the United 
States (Puett et al. 2011) did not show statisti-
cally significant associations between PM2.5 
and all-cause mortality. However, our current 
results are consistent with those from the ACS 
cohort (Pope et al. 2002), the Nurses’ Health 
Study (Puett et al. 2009), and the Medicare 
cohort (Eftim et al. 2008), which indicated 
mortality increases ranging from 3–26% per 
10-µg/m3 increase in PM2.5.
The 26% increase in cardiovascular mor-
tality for each 10-µg/m3 increase in PM2.5 
exposure during the previous 3 years esti-
mated in this extended follow-up is similar 
to the previous estimate (Laden et al. 2006). 
Although the NLCS–Air study (Beelen et al. 
2008b) found no statistically significant asso-
ciation, the magnitude of the estimated effect 
reported here is between the 12% increase 
estimated for the ACS cohort (Pope et al. 
2004) and the 76% increase estimated for the 
Women’s Health Initiative study (Miller et al. 
2007). Puett et al. (2009) also estimated a 
100% increase in fatal coronary heart diseases 
for a 10-µg/m3 increase in PM2.5 during the 
prior year. Underlying mechanisms for the 
effects of PM2.5 on cardiovascular mortality 
are still poorly understood, but changes in 
vasoconstriction might explain the associa-
tions (Anderson et al. 2011).
The previous extended follow-up of the 
Harvard Six Cities study showed an elevated, 
but not statistically significant, risk of lung-
cancer mortality (Laden et al. 2006), whereas 
the present extended follow-up estimated a 
statistically significant 37% increase in lung-
cancer mortality (for each 10-µg/m3 increase 
in PM2.5), which is greater than that estimated 
for both the ACS cohort (14%) (Pope et al. 
2002) and a Japanese cohort (27%) (Katanoda 
et al. 2011). Lungs are one of the organs that 
are most directly affected by particulate air 
pollution. Fine particles, which may carry 
toxic chemicals of carcinogenic potential 
(Laden et al. 2000), can reach lung alveoli 
where the clearance is slow (Pinkerton et al. 
1995) and induce durable pulmonary and sys-
temic inflammation (Riva et al. 2011). Recent 
findings in the ACS cohort indicated that a 
10-µg/m3 increase in PM2.5 concentration 
was associated with a statistically significant 
15% to 27% increase in lung-cancer mor-
tality in never smokers (Turner et al. 2011). 
Table 2. Adjusteda association between PM2.5
b and mortality, for the 8,096 participants and certain sub-
populations of the Harvard Six Cities study, 1974–2009.
Cause of death/stratum-specific estimates 
according to characteristics at enrollment
n participants 
(n person-years)
RR (95% CI) for 10-µg/m3 
increase in PM2.5
All-cause 8,096 (212,067) 1.14 (1.07, 1.22)
Chronic conditionsc
Hypertension 1,439 (30,540) 1.17 (1.03, 1.32)
COPD 942 (17,723) 1.09 (0.95, 1.26)
Diabetes 563 (11,473) 1.04 (0.85, 1.27)
Smoking status (p-interaction = 0.58)
Never smoker 3,265 (90,372) 1.09 (0.98, 1.21)
Former smoker 1,934 (48,049) 1.17 (1.04, 1.30)
Current smoker 2,897 (73,646) 1.17 (1.06, 1.28)
Follow-up period (p-interaction = 0.06)
1974–1982 8,096 (58,798) 1.06 (0.96, 1.17)
1983–1991 7,478 (63,129) 1.32 (1.16, 1.50)
1992–2000 6,391 (51,800) 1.11 (0.98, 1.27)
2001–2009 4,910 (38,340) 1.19 (0.91, 1.55)
Cardiovascular 7,961 (195,941) 1.26 (1.14, 1.40)
Smoking status (p-interaction = 0.45)
Never smoker 3,232 (83,861) 1.21 (1.04, 1.41)
Former smoker 1,891 (44,205) 1.21 (1.02, 1.44)
Current smoker 2,838 (67,875) 1.36 (1.17, 1.58)
Follow-up period (p-interaction = 0.07)
1974–1982 7,961 (42,672) 1.08 (0.92, 1.27)
1983–1991 7,478 (63,129) 1.46 (1.21, 1.76)
1992–2000 6,391 (51,800) 1.30 (1.06, 1.59)
2001–2009 4,910 (38,340) 1.57 (1.01, 2.43)
Lung cancer 7,961 (195,941) 1.37 (1.07, 1.75)
Smoking status (p-interaction = 0.15)
Never smoker 3,232 (83,861) 1.25 (0.54, 2.89)
Former smoker 1,891 (44,205) 1.96 (1.29, 2.99)
Current smoker 2,838 (67,875) 1.25 (0.95, 1.64)
Follow-up period (p-interaction = 0.19)
1974–1982 7,961 (42,672) 1.45 (0.98, 2.15)
1983–1991 7,478 (63,129) 0.94 (0.58, 1.52)
1992–2000 6,391 (51,800) 1.54 (0.98, 2.41)
2001–2009 4,910 (38,340) 2.84 (1.06, 7.59)
COPD 7,805 (180,106) 1.17 (0.85, 1.62)
Smoking status (p-interaction = 0.35)
Never smoker 3,191 (77,422) 0.85 (0.36, 2.02)
Former smoker 1,847 (40,453) 1.64 (0.92, 2.93)
Current smoker 2,767 (62,231) 1.10 (0.74, 1.62)
Follow-up period (p-interaction = 0.35)
1974–1982 7,805 (26,837) 0.79 (0.36, 1.72)
1983–1991 7,478 (63,129) 1.52 (0.90, 2.56)
1992–2000 6,391 (51,800) 1.31 (0.74, 2.31)
2001–2009 4,910 (38,340) 0.68 (0.25, 1.83)
aCox proportional hazards model stratified by sex, age, and time in the study and adjusted for BMI, education, and smok-
ing history. bPM2.5 moving average was 1 year before death or censure for all-cause deaths, 1–3 years for cardio  vascular 
and lung-cancer deaths, and 1–5 years for COPD deaths. cEstimates restricted to participants with the specified chronic 
condition.PM2.5 and mortality: the Harvard Six Cities study
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We did not find such an association in our 
study, which might be due to a lack of statisti-
cal power (350 lung-cancer deaths, 26 among 
never smokers). However, estimated effects of 
PM2.5 on all-cause and cardiovascular mortal-
ity were also statistically significant (or border-
line significant) in never smokers, and higher 
in current smokers compared to never or for-
mer smokers (Table 2).
Regarding COPD mortality, we found 
a positive but not statistically significant risk 
of COPD death associated with PM2.5 expo-
sure. In the ACS cohort, Pope et al. (2004) 
estimated an unexpected inverse association 
between PM2.5 exposure and COPD mortal-
ity, whereas Katanoda et al. (2011) estimated 
an inverse but not statistically significant 
association between PM2.5 and COPD in a 
Japanese cohort.
Chronic conditions at enrollment and 
mortality. The central deposition of parti-
cles in lungs has been shown to be enhanced 
in COPD patients (Bennett et al. 1997). 
Although PM2.5 has been associated with early 
mortality in COPD patients (Zanobetti et al. 
2008), and ozone has been associated with 
early mortality in susceptible subjects (i.e., 
with COPD, diabetes, heart failure, or myo-
cardial infarction) (Zanobetti and Schwartz 
2011), our results did not indicate stronger 
associations in participants with such chronic 
conditions at enrollment compared with the 
population as a whole,. This might have been 
due to a lack of statistical power as few par-
ticipants had COPD (n = 942) or diabetes 
(n = 563) at enrollment.
Exposure assessment. Use of outdoor 
measurements from central monitoring sta-
tions as a proxy measure of mean personal 
exposure to PM2.5 is prone to measurement 
error because the measures do not capture 
fine spatial contrasts that may occur within 
a city, which may bias the results. Recent 
reanalyses of the ACS cohort using land use 
regression models showed that the impact on 
the PM2.5–mortality association was hetero-
geneous depending on the city (Krewski et al. 
2009). However, other recent studies have 
suggested that considering a more precise 
exposure model focused on the home address 
might not improve health effects estimates in 
terms of bias and variance (Kim et al. 2009; 
Lepeule et al. 2010; Szpiro et al. 2011). In 
the Harvard Six Cities study, there were not 
enough monitors in the cities to implement a 
land use regression model.
Strengths and limitations. Our results were 
adjusted for baseline factors, but there is poten-
tial for residual confounding for risk factors 
after enrollment and for unmeasured factors 
such as occupational exposures or medication 
use if those factors co-vary with PM2.5. Some 
other limitations are that we did not measure 
PM2.5 in the same locations throughout the 
study period, that death certificates might have 
listed misclassified specific causes of death, and 
that hypertension and diabetes were assessed 
by questionnaire only. An extensive body of 
methodological work has been performed 
regarding the sensitivity of estimated associa-
tions between long-term exposure to air pollu-
tion and mortality, especially for the ACS and 
Harvard Six Cities study cohorts. More specifi-
cally, it has been shown that results were robust 
to alternative model specifications, alternative 
metrics of PM2.5, and adjustment for indi-
vidual and ecological risk factors such as occu-
pational exposures and socioeconomic variables 
(Krewski et al. 2005a, 2005b). It was also 
shown that using a spatial covariance structure 
did not change the results (Pope et al. 2002), 
but with only six locations, that methodology 
is not applicable in our study. Whereas the 
primary analysis from the Harvard Six Cities 
study (Dockery et al. 1993) estimated asso-
ciations were based on between–city contrasts 
in exposure, in the current study, with age 
used as time scale, the exposure relied on both 
between– and within–city contrasts, limiting 
the potential for residual cross-sectional con-
founding. The strengths of the present study 
are the randomly sampled participants and 
its extended follow-up through 2009, which 
included more observations of participants 
with lower exposures during recent years and 
provided more statistical power.
Critical periods of PM2.5 exposure. Our 
results indicated that the best fit moving aver-
age for PM2.5 was 1 year for all-cause mor-
tality. For cardiovascular and lung-cancer 
mortality, no clear pattern was identified 
because of the high correlation between PM2.5 
concentrations in the 5 lagged years tested. 
These results suggest that PM2.5 exposure 
can act to promote cardiovascular diseases 
and lung-cancer growth, although the design 
of this study precludes us from determining 
whether PM2.5 initiates these diseases as sug-
gested by other studies (Beelen et al. 2008a; 
Beeson et al. 1998). These results agree with 
the literature (Gehring et al. 2006; Krewski 
et al. 2009; Puett et al. 2009; Schwartz et al. 
2008) and suggest that health improvements 
can be expected almost immediately after a 
reduction in air pollution. This conclusion 
should be taken into account for cost–benefit 
analyses related to air pollution standards.
Role of sulfates and public health implica-
tions. Although RRs for PM2.5 fluctuated over 
time, our extended follow-up did not indicate 
any clear pattern over time during the study 
period. Between 1979–1988 (Laden et al. 
2000) and 2009 (Nehls and Akland 1973), the 
sulfates/PM2.5 ratio for exposures measured for 
the Harvard Six Cities study dropped between 
13% and 54%, depending on the city. If sul-
fates are unrelated to mortality, as some have 
argued (Grahame and Schlesinger 2005), the 
elimination of a substantial fraction of non-
toxic material from PM2.5 mass should result 
in a substantial increase in the PM2.5 coef-
ficient, which would otherwise have been sup-
pressed by the large fraction of mass that was 
nontoxic. This was not the case, and hence our 
results indicate that sulfate particles are about 
as toxic as the average fine particle. This is con-
sistent with the results of Pope et al. (2007), 
who found that the 2.5-µg/m3 decrease in sul-
fate particle concentrations observed during an 
8-month smelters strike were associated with a 
2.5% decrease in the number of deaths in the 
region. In comparison, a 2.5-µg/m3 decrease 
in PM2.5 in our follow-up of the Harvard 
Six Cities study was associated with a 3.5% 
reduction in all-cause deaths, but that was for 
reductions in PM2.5 lasting at least a year, not 
Figure 2. Survival probabilities under three hypothetical scenarios: participants of the Harvard Six Cities 
study are exposed to 10, 15, or 20 µg/m3 PM2.5 during the entire follow-up period of 1974–2009.
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8 months. Given that there were 2,423,712 
deaths in the United States in 2007 (Xu et al. 
2010) and that the average PM2.5 level was 
11.9 µg/m3 (U.S. EPA 2011), our estimated 
association between PM2.5 and all-cause mor-
tality implies that a decrease of 1 µg/m3 in 
popu  lation-average PM2.5 would result in 
approximately 34,000 fewer deaths per year.
Conclusion
Including recent observations with PM2.5 expo-
sures well below the U.S. annual standard of 
15 µg/m3 and down to 8 µg/m3, the relation-
ship between chronic exposure to PM2.5 and 
all-cause, cardiovascular, and lung-cancer mor-
tality was found to be linear without a thresh-
old. Our results were not sensitive to various 
model specifications. Furthermore, estimated 
effects of PM2.5 did not change over time, 
suggesting a stable toxicity of PM2.5, even at 
lower exposure levels and with a lower sulfates 
proportion. These results suggest that further 
public policy efforts that reduce fine particulate 
matter air pollution are likely to have continu-
ing public health benefits.
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